Executive summary of the consensus document on metabolic disorders and cardiovascular risk in patients with HIV infection.
| Autor: | Polo Rodríguez R, Galindo Puerto MJ, Dueñas C, Gómez Candela C, Estrada V, Villar NG, Locutura J, Mariño A, Pascua J, Palacios R, Von Wichmman MÁ, Álvarez J, Asensi V, Lopez Aldeguer J, Lozano F, Negredo E, Ortega E, Pedrol E, Gutiérrez F, Sanz Sanz J, Martínez Chamorro E |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Enfermedades infecciosas y microbiologia clinica [Enferm Infecc Microbiol Clin] 2015 Jan; Vol. 33 (1), pp. 41-7. Date of Electronic Publication: 2014 Aug 03. |
| DOI: | 10.1016/j.eimc.2014.05.018 |
| Abstrakt: | The importance of the metabolic disorders and their impact on patients with HIV infection requires an individualized study and continuous updating. HIV patients have the same cardiovascular risk factors as the general population. The HIV infection per se increases the cardiovascular risk, and metabolic disorders caused by some antiretroviral drugs are added risk factors. For this reason, the choice of drugs with a good metabolic profile is essential. The most common metabolic disorders of HIV infected-patients (insulin resistance, diabetes, hyperlipidemia or osteopenia), as well as other factors of cardiovascular risk, such as hypertension, should also be dealt with according to guidelines similar to the general population, as well as insisting on steps to healthier lifestyles. The aim of this document is to provide a query tool for all professionals who treat HIV-patients and who may present or display any metabolic disorders listed in this document. (Copyright © 2014 Elsevier España, S.L.U. y Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. All rights reserved.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|